• Phase

    Alumni community member

  • Contact person

    Paul Hasselgren, CEO

  • Email

    paul.hasselgren@norinvent.com

  • Area

    Pharma & Biotech

NorInvent

NorInvent is a research company in the Life Science sector that develops a drug delivery platform based on unique carbohydrates derived from Proteoglycans. The technique is the result of 20 years research studies by Dr Jonatan Moses. The platform, XtriG, is patented and opens for better properties as well as better profitability for existing drugs. NorInvents platform in based on a specific carbohydrate sequence that, after modification of substituents groups, can connect with various drugs, where the modification pattern of the carbohydrate strain is unique for the given drug.

© 2020 Copyright SmiLe Incubator